124 related articles for article (PubMed ID: 37933030)
1. Association between CD10 expression and phyllodes tumor: A retrospective case control study.
Tian F; Zhao J; Shi QF; Zhang DC; Wang YY; Sun JP; Wang Y; Yang SA; Zhang C
Medicine (Baltimore); 2023 Nov; 102(44):e35677. PubMed ID: 37933030
[TBL] [Abstract][Full Text] [Related]
2. Role of CD10 Immunoexpression in Grading Phyllodes Tumour of the Breast.
Kulkarni MM; Khandeparkar SG; Joshi AR; Kothikar V; Nasare A; Patil S; Niraspatil S; Dhande B
J Clin Diagn Res; 2017 Jan; 11(1):EC14-EC16. PubMed ID: 28273972
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma.
Umekita Y; Yoshida H
Pathol Int; 1999 Sep; 49(9):807-10. PubMed ID: 10504552
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of histological features between core needle biopsy and surgical excision in phyllodes tumor.
Choi J; Koo JS
Pathol Int; 2012 Feb; 62(2):120-6. PubMed ID: 22243782
[TBL] [Abstract][Full Text] [Related]
5. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem.
Krishnamurthy S; Ashfaq R; Shin HJ; Sneige N
Cancer; 2000 Dec; 90(6):342-9. PubMed ID: 11156517
[TBL] [Abstract][Full Text] [Related]
6. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
7. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
Tsai WC; Jin JS; Yu JC; Sheu LF
Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
[TBL] [Abstract][Full Text] [Related]
8. Phyllodes tumors of the breast: clinicopathological analysis of 106 cases from a single institution.
Efared B; Ebang GA; Tahiri L; Sidibé IS; Erregad F; Hammas N; Melhouf MA; Banani A; Chbani L; Fatemi HE
Breast Dis; 2018; 37(3):139-145. PubMed ID: 29332027
[TBL] [Abstract][Full Text] [Related]
9. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade.
Shubham S; Ahuja A; Bhardwaj M
J Lab Physicians; 2019; 11(4):330-334. PubMed ID: 31929699
[TBL] [Abstract][Full Text] [Related]
11. Comparison of stromal CD10 expression in benign, borderline, and malignant phyllodes tumors among Egyptian female patients.
Ibrahim WS
Indian J Pathol Microbiol; 2011; 54(4):741-4. PubMed ID: 22234101
[TBL] [Abstract][Full Text] [Related]
12. Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis.
Sawalhi S; Al-Shatti M
Ann Saudi Med; 2013; 33(2):162-8. PubMed ID: 23563006
[TBL] [Abstract][Full Text] [Related]
13. Phyllodes tumor of the breast: role of CD10 in predicting metastasis.
Al-Masri M; Darwazeh G; Sawalhi S; Mughrabi A; Sughayer M; Al-Shatti M
Ann Surg Oncol; 2012 Apr; 19(4):1181-4. PubMed ID: 22006372
[TBL] [Abstract][Full Text] [Related]
14. Critical appraisal of stromal CD10 staining in fibroepithelial lesions of breast with a special emphasis on expression patterns and correlation with WHO grading.
Puri V; Jain M; Mahajan G; Pujani M
J Cancer Res Ther; 2016; 12(2):667-70. PubMed ID: 27461629
[TBL] [Abstract][Full Text] [Related]
15. Ki67 and P53 Expression in Relation to Clinicopathological Features in Phyllodes Tumour of the Breast.
Mohd Ali NA; Nasaruddin AF; Mohamed SS; Wan Rahman WF
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2653-2659. PubMed ID: 32986365
[TBL] [Abstract][Full Text] [Related]
16. A case of phyllodes tumor of the breast with a lesion mimicking fibroadenoma.
Tomimaru Y; Komoike Y; Egawa C; Motomura K; Inaji H; Kataoka TR; Koyama H
Breast Cancer; 2005; 12(4):322-6. PubMed ID: 16286914
[TBL] [Abstract][Full Text] [Related]
17. Expression of Yes-associated protein (YAP) in breast phyllodes tumor.
Kim SK; Jung WH; Koo JS
Int J Clin Exp Pathol; 2014; 7(9):5997-6005. PubMed ID: 25337244
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
Di Liso E; Bottosso M; Lo Mele M; Tsvetkova V; Dieci MV; Miglietta F; Falci C; Faggioni G; Tasca G; Giorgi CA; Giarratano T; Mioranza E; Michieletto S; Saibene T; Dei Tos AP; Conte P; Guarneri V
ESMO Open; 2020 Oct; 5(5):e000843. PubMed ID: 33020219
[TBL] [Abstract][Full Text] [Related]
19. Fine needle aspiration cytologic features of mammary phyllodes tumors.
Tse GM; Ma TK; Pang LM; Cheung H
Acta Cytol; 2002; 46(5):855-63. PubMed ID: 12365219
[TBL] [Abstract][Full Text] [Related]
20. Analysis of phyllodes tumor recurrence according to the histologic grade.
Kim S; Kim JY; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
